4.7 Article

Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease

期刊

ALZHEIMERS & DEMENTIA
卷 10, 期 6, 页码 743-751

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2013.11.005

关键词

A beta; Cognitive decline; Preclinical AD; Prodromal AD; Neuropsychology

资金

  1. CSIRO
  2. Edith Cowan University
  3. Mental Health Research Institute
  4. Alzheimer's Australia
  5. National Ageing Research Institute
  6. Austin Health, CogState, Ltd.
  7. Hollywood Private Hospital
  8. Sir Charles Gardner Hospital
  9. National Health and Medical Research Council (NHMRC)
  10. Dementia Collaborative Research Centres program
  11. Science and Industry Endowment Fund
  12. Janssen
  13. Pfizer Inc.
  14. Eli Lilly and Company
  15. GlaxoSmithKline
  16. Forest Laboratories, Inc.
  17. Novartis
  18. Bayer Schering Pharma
  19. Avid Radiopharmaceuticals, Inc.
  20. Alzheimer's Association
  21. ESA
  22. Epilepsy Fellowship
  23. Bio21
  24. Pharmacogenetics Overseas Training Scholarship
  25. RACP
  26. Alzheimer's Association of Australia
  27. Scobie and Claire McKinnon Foundation
  28. Collier Foundations
  29. Brain Foundation
  30. NHMRC, Japan
  31. NEDO, Japan

向作者/读者索取更多资源

Background: High beta-amyloid (A beta) is associated with faster memory decline in healthy individuals and adults with mild cognitive impairment (MCI). However, longer prospective studies are required to determine if A beta-related memory decline continues and whether it is associated with increased rate of disease progression. Methods: Healthy controls (HCs; n = 177) and adults with MCI (n = 48) underwent neuroimaging for A beta and cognitive assessment at baseline. Cognition was reassessed 18 and 36 months later. Results: Compared with low-A beta HCs, high-A beta HC and MCI groups showed moderate decline in episodic and working memory over 36 months. Those with MCI with low A beta did not show any cognitive decline. Rates of disease progression were increased in the high-A beta HC and MCI groups. Conclusions: In healthy individuals, high A beta likely indicates that Alzheimer's disease (AD)-related neurodegeneration has begun. Once commenced, the rate of decline in cognitive function remains constant across the preclinical and prodromal stages of AD. (C) 2014 Published by Elsevier Inc. on behalf of The Alzheimer's Association.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort

Pratishtha Chatterjee, Steve Pedrini, James D. Doecke, Rohith Thota, Victor L. Villemagne, Vincent Dore, Abhay K. Singh, Penghao Wang, Stephanie Rainey-Smith, Christopher Fowler, Kevin Taddei, Hamid R. Sohrabi, Mark P. Molloy, David Ames, Paul Maruff, Christopher C. Rowe, Colin L. Masters, Ralph N. Martins

Summary: This study investigated the changes in several blood biomarkers across the AD continuum and their associations with cognitive decline and brain Aβ-PET load. The results showed that plasma Aβ1-42/Aβ1-40 ratio decreased, p-tau181 and GFAP increased in predicting the β-amyloid positive/negative status across the AD continuum.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A beta-PET, neurodegeneration, and cognition

Pratishtha Chatterjee, Lisa Vermunt, Brian A. Gordon, Steve Pedrini, Lynn Boonkamp, Nicola J. Armstrong, Chengjie Xiong, Abhay K. Singh, Yan Li, Hamid R. Sohrabi, Kevin Taddei, Mark Molloy, Tammie L. S. Benzinger, John C. Morris, Celeste Karch, Sarah Berman, Jasmeer Chhatwal, Carlos Cruchaga, Neill R. Graff-Radford, Gregory S. Day, Martin Farlow, Nick Fox, Alison Goate, Jason Hassenstab, Jae-Hong Lee, Johannes Levin, Eric McDade, Hiroshi Mori, Richard Perrin, Raquel Sanchez-Valle, Peter R. Schofield, Allan Levey, Mathias Jucker, Colin L. Masters, Anne M. Fagan, Randall J. Bateman, Ralph N. Martins, Charlotte Teunissen

Summary: This study found that plasma GFAP levels increase a decade before symptom onset in AD and are associated with Aβ load, neurodegeneration, and cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Review Nutrition & Dietetics

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

Carolina B. Castro, Cintia B. Dias, Heidi Hillebrandt, Hamid R. Sohrabi, Pratishtha Chatterjee, Tejal M. Shah, Stephanie J. Fuller, Manohar L. Garg, Ralph N. Martins

Summary: This systematic review and meta-analysis examined the effects of medium-chain fatty acid (MCFA) supplementation on circulating ketone bodies and cognition in individuals with cognitive decline and Alzheimer's disease. The results showed that MCFA supplementation increases blood ketone levels and enhances brain energy metabolism. However, the effects on cognition varied and further research is needed to determine if MCFA-mediated increase in brain energy metabolism can improve cognition.

NUTRITION REVIEWS (2023)

Article Multidisciplinary Sciences

Theta tACS impairs episodic memory more than tDCS

Nicholas W. G. Murray, Petra L. L. Graham, Paul F. F. Sowman, Greg Savage

Summary: Episodic memory deficits are common in aging and neurodegenerative disorders. Transcranial electrical stimulation (TES) is a promising tool for memory enhancement, but the optimal stimulation parameters are not yet determined. In a double-blind, randomized, sham-controlled study, applying TES over the left temporal lobe resulted in a decrease in word recall and an increase in memory errors compared to sham stimulation.

SCIENTIFIC REPORTS (2023)

Article Psychology, Educational

Development of complex executive function over childhood: Longitudinal growth curve modeling of performance on the Groton Maze Learning Task

Thomas B. McGuckian, Peter H. Wilson, Rich D. Johnston, Shahin Rahimi-Golkhandan, Jan Piek, Dido Green, Jeffrey M. Rogers, Paul Maruff, Bert Steenbergen, Scott Ruddock

Summary: This longitudinal study examined the development of children's complex executive function (EF) using the Groton Maze Learning Task (GMLT). A total of 147 children (61 males, ages 5.5-11 years) were recruited from six multicultural primary schools in Melbourne and Perth, Australia. The study spanned from 2010 to 2012, with assessments on the GMLT conducted every 6 months. Growth curve models indicated a quadratic growth trajectory in each measure of error, reflecting visuospatial memory, executive control, and complex EF. The ability to apply rules for action, a key aspect of complex EF, developed rapidly during early-to-mid childhood.

CHILD DEVELOPMENT (2023)

Article Neurosciences

Physical Activity for Cognitive Health: A Model for Intervention Design for People Experiencing Cognitive Concerns and Symptoms of Depression or Anxiety

Eleanor Curran, Victoria J. Palmer, Kathryn A. Ellis, Terence W. H. Chong, Thomas Rego, Kay L. Cox, Kaarin J. Anstey, Alissa Westphal, Rebecca Moorhead, Jenny Southam, Rhoda Lai, Emily You, Nicola T. Lautenschlager

Summary: This study aimed to develop a specified model to guide interventions for people experiencing depressive or anxiety symptoms and cognitive concerns in order to optimize physical activity engagement and reduce dementia risk. The findings suggest that individuals in this population require tailored interventions to improve their participation in physical activities.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Neurosciences

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease

Pratishtha Chatterjee, Vincent Dore, Steve Pedrini, Natasha Krishnadas, Rohith Thota, Pierrick Bourgeat, Milos D. Ikonomovic, Stephanie R. Rainey-Smith, Samantha C. Burnham, Christopher Fowler, Kevin Taddei, Rachel Mulligan, David Ames, Colin L. Masters, Jurgen Fripp, Christopher C. Rowe, Ralph N. Martins, Victor L. Villemagne

Summary: Astrocyte reactivity is associated with the elevation of plasma glial fibrillary acidic protein (GFAP) and monoamine oxidase-B (MAO-B) in Alzheimer's disease. The association between plasma GFAP and regional F-18-SMBT-1 PET is dependent on brain β-amyloid (Aβ) load.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Health Care Sciences & Services

Examination of the Feasibility, Acceptability, and Efficacy of the Online Personalised Training in Memory Strategies for Everyday Program for Older Adults: Single-Arm Pre-Post Trial

Kerryn Pike, Carl Moller, Christina Bryant, Maree Farrow, Duy P. Dao, Kathryn A. Ellis

Summary: This study evaluated the feasibility, acceptability, and efficacy of the Online Personalised Training in Memory Strategies for Everyday (OPTIMiSE) program, a web-based intervention for older adults with cognitive decline. The results showed that OPTIMiSE was feasible, acceptable, and efficacious, with improvements in memory, strategy knowledge and use, and mood. The participants reported significant changes in strategy use, daily life improvements, reduced concern about memory, and increased confidence and self-efficacy, which were consistent with previous in-person interventions. This web-based program has the potential to provide evidence-based memory interventions for older adults worldwide.

JOURNAL OF MEDICAL INTERNET RESEARCH (2023)

Article Psychology, Clinical

Linking Self-Perceived Cognitive Functioning Questionnaires Using Item Response Theory: The Subjective Cognitive Decline Initiative

Laura A. Rabin, Sietske A. M. Sikkes, Douglas Tommet, Richard N. Jones, Paul K. Crane, Milushka M. Elbulok-Charcape, Mark A. Dubbelman, Rebecca Koscik, Rebecca E. Amariglio, Rachel F. Buckley, Merce Boada, Gael Chetelat, Bruno Dubois, Kathryn A. Ellis, Katherine A. Gifford, Angela L. Jefferson, Frank Jessen, Sterling Johnson, Mindy J. Katz, Richard B. Lipton, Tobias Luck, Eleni Margioti, Paul Maruff, Jose Luis Molinuevo, Audrey Perrotin, Ronald C. Petersen, Lorena Rami, Barry Reisberg, Dorene M. Rentz, Steffi G. Riedel-Heller, Shannon L. Risacher, Octavio Rodriguez-Gomez, Perminder S. Sachdev, Andrew J. Saykin, Nikolaos Scarmeas, Colette Smart, Beth E. Snitz, Reisa A. Sperling, Vanessa Taler, Wiesje M. van der Flier, Argonde C. van Harten, Michael Wagner, Steffen Wolfsgruber

Summary: This study aimed to link self-perceived cognitive functioning data from international aging studies using item response theory. The results demonstrated that a single-factor structure was reasonable for the latent trait, and identified top items that made the greatest contribution to measurement precision. This allows for joint or pooled analyses across international studies and may lead to the development of new self-perceived cognitive functioning questionnaires.

NEUROPSYCHOLOGY (2023)

Article Psychology, Clinical

Multidomain Modifiable Dementia Risk Factors Are Associated With Poorer Cognition in Midlife

Lisa Bransby, Emily Rosenich, Rachel F. Buckley, Nawaf Yassi, Matthew P. Pase, Paul Maruff, Yen Ying Lim

Summary: This study aimed to determine the frequency and co-occurrence of modifiable dementia risk factors (MDRFs) in a large sample of middle-aged adults. The results showed that most individuals reported MDRFs in two or more domains, and these multidomain MDRFs were related to poorer cognition.

NEUROPSYCHOLOGY (2023)

Review Behavioral Sciences

Frontal variant Alzheimer's disease: A systematic narrative synthesis

Andrea Brown, Sarah K. Salo, Greg Savage

Summary: This narrative synthesis summarizes the cognitive profiles of frontal variant Alzheimer's disease (fvAD) and highlights the need for further investigation into differential diagnostic markers, such as executive dysfunction and behavioral symptoms. It also reveals some similarities between fvAD and typical AD, which may guide future research in disease diagnosis.

CORTEX (2023)

Article Clinical Neurology

Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies

John J. Alam, Paul Maruff, Susan R. Doctrow, Hui-May Chu, Jennifer Conway, Stephen N. Gomperts, Charlotte Teunissen

Summary: This study evaluates the relationship between plasma tau phosphorylated at residue 181 (ptau181), a biomarker of Alzheimer disease (AD) copathology, and the treatment effects of the p38 alpha kinase inhibitor neflamapimod in patients with dementia with Lewy bodies (DLB). The results suggest that DLB patients with lower pretreatment ptau181 levels may show better treatment response to neflamapimod, with improvement in attention, cognitive assessment, and daily functioning. Plasma biomarkers of AD copathology should be considered as stratification variables in DLB clinical trials.

NEUROLOGY (2023)

Article Geriatrics & Gerontology

Effects of a Multi-component, Resistance-Based Exercise Program Combined with Additional Lean Red Meat on Health-Related Quality of Life in Older Adults: Secondary Analysis of a 6-Month Randomized Controlled Trial

M. B. Formica, J. Gianoudis, C. A. Nowson, S. L. O'Connell, C. Milte, K. A. Ellis, Robin M. Daly

Summary: This study found that consuming lean red meat on three exercise training days per week did not promote greater improvements in health-related quality of life compared to exercise alone in community-dwelling older adults.

JOURNAL OF NUTRITION HEALTH & AGING (2023)

Review Neurosciences

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease

Matin Ramezani, Malika Fernando, Shaun Eslick, Prita R. Asih, Sina Shadfar, Ekanayaka M. S. Bandara, Heidi Hillebrandt, Silochna Meghwar, Maryam Shahriari, Pratishtha Chatterjee, Rohith Thota, Cintia B. Dias, Manohar L. Garg, Ralph N. Martins

Summary: Alzheimer's disease is the most common form of dementia, characterized by cognitive dysfunction and behavioral changes. Pathological markers and neural damage in AD are associated with altered brain energy metabolism. The ketogenic diet has been shown to increase ketone body production, improving brain energy metabolism and potentially affecting AD biomarkers and neuroinflammation.

FRONTIERS IN NEUROSCIENCE (2023)

Article Geriatrics & Gerontology

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults

Jun Yuan, Steve Pedrini, Rohith Thota, James Doecke, Pratishtha Chatterjee, Hamid R. Sohrabi, Charlotte E. Teunissen, Inge M. W. Verberk, Erik Stoops, Hugo Vanderstichele, Bruno P. Meloni, Christopher Mitchell, Stephanie Rainey-Smith, Kathryn Goozee, Andrew Chi Pang Tai, Nicholas Ashton, Henrik Zetterberg, Kaj Blennow, Junjie Gao, Delin Liu, Frank Mastaglia, Charles Inderjeeth, Minghao Zheng, Ralph N. Martins

Summary: This study investigated the association between plasma SOST levels and brain amyloid-beta load in older individuals. The results showed that plasma SOST levels were higher in individuals with brain amyloid-beta load, and the combination of plasma SOST and Aβ 42/Aβ40 ratio improved the predictive accuracy for preclinical Alzheimer's disease.

NPJ AGING (2023)

暂无数据